Sotera Health Company (SHC) stock soared 6.44% in pre-market trading on Tuesday following the release of its strong third-quarter 2025 financial results and an improved full-year outlook. The healthcare sterilization and lab testing services provider reported better-than-expected earnings and revenue, demonstrating resilience in its business model.
The company reported Q3 adjusted earnings per share of $0.26, surpassing analyst estimates of $0.22. Revenue for the quarter came in at $311.3 million, exceeding the consensus forecast of $303.6 million. This represents a 9.1% year-over-year increase in net revenues. Adjusted EBITDA rose 12.2% to $164 million, also beating analyst expectations of $155.5 million.
Encouraged by its strong performance, Sotera Health raised its full-year 2025 outlook. The company now expects Adjusted EBITDA growth in the range of 6.75% to 7.75%, up from the previous guidance of 6.00% to 7.50%. Additionally, Sotera Health increased its adjusted EPS guidance to $0.81-$0.86 for the year. The company reaffirmed its net revenues growth outlook of 4.5% to 6.0% on a constant currency basis. These positive results and optimistic projections have likely fueled investor confidence, contributing to the significant pre-market stock movement.
Comments